"Prevalence and incidence of multiple sclerosis (MS) in the childhood and adolescence is not exactly known. Children with MS are estimated between 2,7% to 5,6% of all patients with MS throughout the world."@en . "Prevalence ani incidence roztrou\u0161en\u00E9 skler\u00F3zy (RS) v d\u011Btsk\u00E9m v\u011Bku a dosp\u00EDv\u00E1n\u00ED nen\u00ED p\u0159esn\u011B zn\u00E1ma. D\u011Bt\u00ED s RS se odhaduje mezi 2,7 % a\u017E 5,6 % ze v\u0161ech \u00FApacient\u016F s RS na cel\u00E9m sv\u011Bt\u011B." . "Multiple sclerosis in patients of adolescent age"@en . . "6"^^ . "Roztrou\u0161en\u00E1 skler\u00F3za u pacient\u016F v adolescentn\u00EDm v\u011Bku"@cs . . "Roztrou\u0161en\u00E1 skler\u00F3za u pacient\u016F v adolescentn\u00EDm v\u011Bku" . "natalizumab; diseases modifying therapy; acute treatment; juvenile multiple sclerosis; infantile multiple sclerosis"@en . . "1213-1814" . "1"^^ . . "Roztrou\u0161en\u00E1 skler\u00F3za u pacient\u016F v adolescentn\u00EDm v\u011Bku"@cs . "I" . "11150" . "2"^^ . "CZ - \u010Cesk\u00E1 republika" . "Prevalence ani incidence roztrou\u0161en\u00E9 skler\u00F3zy (RS) v d\u011Btsk\u00E9m v\u011Bku a dosp\u00EDv\u00E1n\u00ED nen\u00ED p\u0159esn\u011B zn\u00E1ma. D\u011Bt\u00ED s RS se odhaduje mezi 2,7 % a\u017E 5,6 % ze v\u0161ech \u00FApacient\u016F s RS na cel\u00E9m sv\u011Bt\u011B."@cs . . "http://www.neurologiepropraxi.cz/pdfs/neu/2013/03/08.pdf" . "RIV/00216208:11150/13:10193080" . . . "Tal\u00E1bov\u00E1, Marika" . "RIV/00216208:11150/13:10193080!RIV14-MSM-11150___" . "Roztrou\u0161en\u00E1 skler\u00F3za u pacient\u016F v adolescentn\u00EDm v\u011Bku" . "Neurologie pro praxi" . . . "Tal\u00E1b, Radom\u00EDr" . . "[602C99BF3A0E]" . . "103657" . . . "3" . . . "Multiple sclerosis in patients of adolescent age"@en . "14" . . .